Psittacine Bornavirus Genotypes and PDD
Overview and Taxonomy of Psittacine Bornavirus Genotypes and PDD
The etiological landscape of proventricular dilatation disease (PDD) in psittacine birds underwent a paradigm shift in 2008 when avian bornavirus (ABV), now more precisely termed parrot bornavirus (PaBV), was definitively established as the causative agent of this devastating neurologic and gastrointestinal disorder [2, 6]. Prior to this landmark discovery, PDD, originally described as “macaw wasting syndrome” or “proventricular dilatation syndrome”, had perplexed avian clinicians and pathologists for decades, with hypotheses ranging from nutritional deficiencies to autoimmune etiologies. The subsequent molecular characterization of these viruses has revealed a complex and expanding genotypic diversity that continues to shape our understanding of viral pathogenesis, host susceptibility, and epidemiological dynamics across captive psittacine populations globally.
Taxonomic Framework and Nomenclature
The taxonomic positioning of psittacine bornaviruses situates them within the family Bornaviridae, order Mononegavirales, a grouping of non-segmented, negative-sense single-stranded RNA viruses. The International Committee on Taxonomy of Viruses (ICTV) has designated the species infecting psittacines as Psittaciform orthobornavirus, a classification that distinguishes these viruses from the mammalian bornaviruses (Mammalian orthobornavirus, which includes Borna disease virus 1 and 2) and the passeriform orthobornaviruses found in carrion birds [3]. This taxonomic distinction carries profound biological implications, as psittacine bornaviruses exhibit host restriction patterns, tissue tropism, and pathogenic mechanisms that diverge significantly from their mammalian counterparts.
The nomenclature conventions employed in the contemporary literature reflect an evolving understanding of viral diversity. Early studies frequently employed the umbrella term “avian bornavirus (ABV)” followed by genotypic designations (ABV-1 through ABV-8) [3, 4]. However, as molecular surveillance expanded globally, the field has increasingly adopted the more specific designation “parrot bornavirus (PaBV)” to emphasize the primary host reservoir and to avoid confusion with bornaviruses detected in passerine species [1, 2, 5]. The phylogenetic analyses underpinning this classification system rely heavily on sequencing of the nucleoprotein (N) gene, matrix (M) gene, and the phosphoprotein (X)/glycoprotein (G) gene regions, with the N gene providing particularly robust resolution for genotypic discrimination [1, 6].
Genotypic Diversity and Global Distribution
The contemporary understanding of psittacine bornavirus genotypic diversity recognizes at least eight distinct genotypes (PaBV-1 through PaBV-8), with genotypes 2, 4, and 1 emerging as the most frequently documented variants across geographically disparate captive populations [2, 6]. This genotypic landscape, however, remains incompletely characterized, and ongoing surveillance efforts continue to reveal previously unrecognized variants, suggesting that the true diversity of these viruses may be substantially underestimated.
PaBV-4 has emerged as the predominant genotype in multiple geographic regions, representing a lineage of particular epidemiological significance. In Thailand, molecular surveillance of 231 captive psittacine birds across three families (Psittaculidae, Psittacidae, and Cacatuidae) demonstrated PaBV-4 as the most prevalent variant, with phylogenetic analyses further resolving this genotype into two distinct subclusters [1]. Notably, PaBV-4 was the sole genotype identified in South African investigations of naturally infected blue and gold macaws (Ara ararauna) exhibiting classic PDD pathology, including lymphoplasmacytic encephalitis and gastrointestinal myenteric ganglioneuritis [3]. The Brazilian captive psittacine experience mirrors this pattern, with PaBV-4 detected across multiple species in both commercial and conservation breeding facilities, achieving infection rates of 69-89% in facilities with documented PDD cases [5]. In Taiwan, surveillance efforts detected PaBV-4 alongside PaBV-2 through X/P gene sequencing of brain tissues from birds with confirmed meningoencephalitis and dilated cardiomyopathy [2].
PaBV-2 represents the second most frequently encountered genotype in contemporary surveillance studies. The Taiwanese investigation documented PaBV-2 co-circulating with PaBV-4, with phylogenetic analyses confirming their distinct genetic clustering [2]. Similarly, the Thai molecular characterization study identified PaBV-2 in their captive populations, albeit at lower prevalence than PaBV-4 [1]. The clinical significance of genotype-specific pathogenicity remains an area of active investigation, as both genotypes have been associated with the full spectrum of PDD pathology, from asymptomatic carrier states to fatal neurological and gastrointestinal disease.
PaBV-1, historically the first genotype characterized in psittacine bornavirus research, continues to represent a significant lineage in North American captive populations. Immunohistochemical investigations utilizing polyclonal sera specific for the viral nucleocapsid (N) protein have provided detailed insights into PaBV-1 tissue distribution, demonstrating viral antigen in neurons, astroglia, and ependymal cells of the central nervous system, as well as in peripheral neurons and adrenal cells [4]. Critically, these studies revealed that viral antigen distribution patterns correlate with clinical status: birds with overt PDD exhibited antigen largely restricted to neuroectodermal cells, while asymptomatic carriers displayed more widespread distribution encompassing epithelial cells of the alimentary and urogenital tracts, retina, myocardium, skeletal muscle, and skin [4]. This differential tropism may have profound implications for transmission dynamics and diagnostic strategies.
Molecular Epidemiology and Prevalence Patterns
The implementation of molecular diagnostic techniques, particularly nested reverse transcription polymerase chain reaction (RT-PCR) targeting the highly conserved nucleoprotein gene, has enabled systematic prevalence assessments across diverse geographic regions and husbandry contexts [1, 6]. The prevalence data emerging from these investigations reveal striking geographical variation that likely reflects differences in biosecurity practices, population density, trade networks, and surveillance intensity.
In South America, Brazilian investigations of captive breeding facilities documented PaBV infection rates of 73.7% across 38 psittacine birds representing 21 species, with commercial facilities exhibiting higher prevalence (88.9%) than conservation-oriented breeding centers (69%) [5]. This disparity likely reflects differences in population management, quarantine protocols, and the intensity of veterinary surveillance between facility types. The Taiwanese experience revealed a prevalence rate of 45.97% across 124 tested psittacine birds, with the highest infection rates occurring during spring (68%) and the lowest during summer (25%), suggesting possible seasonal influences on viral transmission or host susceptibility [2]. In Southeast Asia, the Thai molecular survey documented a comparatively lower prevalence of 13.85% among 231 captive birds across five geographical regions [1]. European data from Poland, spanning a decade of surveillance (2014-2024), demonstrated PaBV RNA in 23.8% of necropsy samples from 210 naturally deceased captive parrots [6].
These prevalence disparities across geographical regions warrant careful interpretation. Differences in diagnostic methodology, sampling strategies (ante-mortem swabs versus post-mortem tissue collections), and the clinical status of sampled populations likely contribute to the observed variation. The Thai study's reliance on choanal swabs, cloacal swabs, and feather sampling, which may yield lower sensitivity than tissue-based approaches, could partially explain their lower detection rates [1]. Conversely, the Polish investigation's use of necropsy tissues from naturally deceased birds may bias toward higher detection rates, as PaBV-positive birds are overrepresented in mortality cohorts [6].
The Carrier State and Subclinical Infection
One of the most epidemiologically significant findings emerging from contemporary molecular surveillance is the documentation of frequent asymptomatic PaBV carriage. The Thai investigation revealed that 81.58% of PaBV-positive birds were clinically normal at the time of sampling, demonstrating no signs of gastrointestinal or neurological dysfunction [1]. This observation aligns with the Brazilian study, where 27.6% of birds in one facility and a substantial proportion in another lacked clinical signs despite confirmed PaBV infection and, in many cases, the presence of histopathological lesions consistent with PDD [5]. Similarly, the Polish necropsy survey documented that 32 of 50 PaBV-positive birds (64%) lacked gross pathological evidence of proventricular or ventricular dilatation at post-mortem examination [6].
The phenomenon of subclinical infection carries profound implications for disease management and biosecurity. Asymptomatic carriers represent cryptic reservoirs capable of shedding virus into the environment, potentially facilitating transmission to susceptible conspecifics without triggering clinical suspicion or quarantine intervention. The immunohistochemical demonstration of widespread viral antigen distribution in asymptomatic PaBV-1 carriers, including epithelial cells of the alimentary tract, provides a mechanistic basis for fecal-oral and potentially environmental transmission pathways [4]. This carrier state complicates eradication efforts, as visual assessment of flock health cannot reliably identify infected individuals, necessitating molecular surveillance for accurate prevalence determination.
Histopathological Correlates of Infection
The pathological manifestation of PaBV infection spans a spectrum from subclinical carriage to fulminant, fatal disease characterized by severe meningoencephalitis, myenteric ganglioneuritis, and leiomyositis of the gastrointestinal tract [2, 3, 6]. The classic PDD lesion complex includes lymphoplasmacytic infiltration of the central and peripheral nervous systems, with particular tropism for the autonomic ganglia innervating the proventriculus and ventriculus [3, 5]. In Taiwanese cases, histopathological examination revealed severe meningoencephalitis in the cerebellum and dilated cardiomyopathy, expanding the recognized spectrum of PaBV-associated pathology beyond the gastrointestinal tract [2]. Immunohistochemical detection of PaBV antigen in South African cases demonstrated positive labeling of neurons, glial cells, myenteric ganglia, nerve fibers, and even smooth muscle cells of the gastrointestinal tract, with one case exhibiting peripheral nerve involvement [3].
The proportion of infected birds progressing from subclinical carriage to clinical PDD appears to vary substantially across populations. The Polish decade-long survey documented that only 36% of PaBV-positive birds exhibited the classic proventricular and ventricular dilatation characteristic of end-stage PDD at necropsy [6]. This observation suggests that factors beyond viral genotype, including host genetics, immune status, co-infections, environmental stressors, and potentially viral load, influence the probability of clinical disease expression.
Transmission Dynamics and Conservation Implications
The molecular evidence for PaBV transmission dynamics raises urgent questions about routes of viral spread within and between captive populations. The South African investigation, which detected identical viral sequences in three young blue and gold macaws from the same breeding facility, raised the possibility of vertical transmission from parent to offspring [3]. This hypothesis gains additional support from the detection of PaBV in juvenile birds and the presence of viral antigen in reproductive tissues of asymptomatic carriers [4]. Horizontal transmission via fecal-oral routes, environmental contamination, and potentially fomites represents an additional pathway supported by the detection of viral RNA in cloacal and choanal swabs from clinically normal carriers [1, 5].
The conservation implications of PaBV circulation in captive breeding programs are particularly concerning. The Brazilian investigation documented that 15.8% of PaBV-positive birds belonged to species classified as threatened, including several South American psittacines of conservation concern [5]. The Thai surveillance identified the continued presence of PaBV in captive populations as a potential threat to native wild psittacines, several of which are classified as “Near Threatened” by the International Union for Conservation of Nature (IUCN) [1]. The World Organisation for Animal Health (WOAH) has recognized the significance of psittacine bornaviruses as emerging pathogens of conservation importance, though international trade regulations and health certification requirements for these viruses remain inconsistent across jurisdictions. The Food and Agriculture Organization of the United Nations (FAO) has similarly highlighted the need for improved biosecurity protocols in captive breeding operations to prevent spillover into wild populations, particularly in regions where endemic psittacine diversity is highest.
Co-infection Dynamics
The practical reality of psittacine viral ecology involves frequent co-infections that may modify disease expression and complicate diagnostic interpretation. The Polish investigation systematically documented concurrent viral infections in their necropsy cohort, detecting beak and feather disease virus (BFDV) in 28% and avian polyomavirus (APyV) in 31% of sampled birds [6]. The potential for synergistic or antagonistic interactions between these viruses remains poorly characterized, though immunosuppressive effects of BFDV infection could plausibly increase susceptibility to PaBV or enhance viral replication in co-infected individuals. These co-infection dynamics underscore the importance of comprehensive viral surveillance rather than targeted testing for individual pathogens.
Molecular Pathogenesis of Psittacine Bornavirus and Proventricular Dilatation Disease
The molecular pathogenesis of Psittacine Bornavirus (PaBV) and its associated clinical syndrome, Proventricular Dilatation Disease (PDD), represents a complex interplay between viral tropism, host immune response, and progressive neuro-gastrointestinal pathology. Since the definitive identification of avian bornaviruses as the etiological agents of PDD in 2008, a substantial body of evidence has elucidated the mechanisms by which these negative-sense, single-stranded RNA viruses of the family Bornaviridae induce disease in psittacine birds [6]. Unlike many acute viral infections, PaBV establishes a persistent, non-cytolytic infection that gradually undermines the structural and functional integrity of the nervous system, leading to the characteristic clinical and pathological hallmarks of PDD. Understanding this pathogenesis at a molecular level is critical for developing diagnostic strategies, therapeutic interventions, and biosecurity protocols for captive populations worldwide.
Viral Entry, Cellular Tropism, and the Nucleoprotein Axis
The initial steps of PaBV infection are governed by the virus’s ability to bind to and enter susceptible host cells. While the specific cellular receptor for PaBV remains to be definitively characterized, the virus demonstrates a pronounced and highly selective tropism for cells of neuroectodermal origin. This includes neurons, astrocytes, oligodendrocytes, and ependymal cells within the central nervous system (CNS), as well as neurons of the peripheral nervous system (PNS) and myenteric ganglia [3, 4]. The viral nucleoprotein (N) is a central molecular player in this process. As demonstrated by immunohistochemical studies using polyclonal sera specific for the N protein, viral antigen is detected within both the nucleus and cytoplasm of infected cells, a hallmark of bornavirus replication that involves a unique nuclear phase [4]. The N protein not only encapsulates the viral RNA genome but also facilitates the transport of the ribonucleoprotein complex into the nucleus, where transcription and replication occur. This nuclear localization is a key pathogenic feature, allowing the virus to hijack host cellular machinery while potentially evading certain cytoplasmic innate immune sensors.
The distribution of viral antigen is not uniform across all infected birds, and this heterogeneity provides profound insight into the molecular pathogenesis of PDD. In birds exhibiting full-blown clinical signs and classic PDD lesions, viral antigen is largely restricted to neuroectodermal cells, neurons, glial cells, and adrenal medullary cells [4]. This restricted pattern suggests that the clinical disease is a direct consequence of neuronal dysfunction and loss rather than widespread cytolytic damage to other tissues. Conversely, in a subset of infected birds that lack clinical signs and PDD lesions, viral antigen exhibits a far more widespread distribution, extending to epithelial cells of the alimentary and urogenital tracts, retina, cardiac and skeletal muscle, and skin [4]. This observation is critical for understanding the carrier state. It implies that early or subclinical infection may involve a broader cellular permissiveness, but as the infection progresses or as the host immune response matures, the virus may become more restricted to its primary neuroectodermal niche. This phenomenon underscores the importance of the carrier state, where birds can shed virus without overt illness, as documented in epidemiological studies from Thailand, where 81.58% of positive cases were asymptomatic [1].
Neuroinvasion and the Pathogenesis of Ganglioneuritis
The cardinal pathological lesion of PDD is a lymphoplasmacytic ganglioneuritis, particularly affecting the myenteric and submucosal plexi of the gastrointestinal tract, accompanied by a non-suppurative encephalitis and myelitis [2, 3]. The molecular mechanism driving this inflammation is a targeted immune response against virus-infected cells within the nervous system. Following entry into the host, likely via the oronasal route, PaBV is thought to gain access to the CNS through peripheral nerve endings, traveling via retrograde axonal transport to the cell bodies of neurons in the brainstem and spinal cord. This neurotropic pathway explains the frequent involvement of the vagus nerve and the celiac ganglia, which innervate the proventriculus and gizzard.
Once established within neurons and glial cells, viral replication triggers a host immune response. The infiltration of lymphocytes and plasma cells into the perivascular spaces and neural parenchyma, a process known as perivascular cuffing, is a hallmark of the disease [2, 3]. This inflammatory infiltrate is not merely a bystander effect; it is a primary driver of tissue damage. The release of cytokines and cytotoxic molecules by infiltrating immune cells contributes to demyelination, axonal degeneration, and neuronal death. The destruction of myenteric ganglia is particularly devastating, as these ganglia are responsible for coordinating the peristaltic waves that move ingesta through the gastrointestinal tract. Loss of this neural control leads to functional ileus, stasis of food, and subsequent dilation of the proventriculus and gizzard, the macroscopic hallmark of PDD [5, 6]. The severity of the neurological component is underscored by findings from Taiwan, where histopathology revealed severe meningoencephalitis in the cerebellum of affected birds, correlating with clinical neurological signs such as ataxia and proprioceptive deficits [2].
Genotypic Variation and Pathogenic Potential
The molecular pathogenesis of PDD is further complicated by the existence of multiple PaBV genotypes. While at least eight genotypes have been described, PaBV-2 and PaBV-4 are the most frequently identified in clinical cases globally [1, 2, 5]. The question of whether specific genotypes are associated with distinct pathogenic profiles or disease severity remains a critical area of investigation. Phylogenetic analyses of the matrix (M) and nucleoprotein (N) genes have been instrumental in classifying these variants. In South America, genotype PaBV-4 was exclusively identified in a study of Brazilian captive parrots, where it was associated with a high prevalence of PDD lesions (100% in one aviary) and a mortality rate that severely impacted conservation efforts for threatened species [5]. Similarly, the first molecular confirmation of PaBV in South Africa identified genotype 4 in blue and gold macaws with classic histopathological lesions, including lymphoplasmacytic encephalitis and gastrointestinal myenteric ganglioneuritis [3].
The predominance of PaBV-4 in many studies raises the possibility that this genotype may possess a higher degree of neurovirulence or transmissibility compared to others. However, PaBV-2 is also a significant pathogen, having been detected in symptomatic birds in Taiwan and Thailand [1, 2]. The identical sequence of the analyzed genome fragment from three young birds in the South African study, all originating from the same breeding facility, raises the critical question of vertical transmission [3]. If PaBV can be transmitted from parent to offspring, this has profound implications for the molecular pathogenesis of the disease, as it suggests that infection can occur very early in development, potentially leading to immune tolerance and a higher likelihood of a persistent, asymptomatic carrier state. This molecular evidence for potential vertical transmission aligns with the high prevalence rates observed in closed breeding facilities, where the virus can become endemic [5].
The Carrier State: A Molecular and Epidemiological Paradox
One of the most challenging aspects of PaBV pathogenesis is the existence of a robust carrier state. Epidemiological data consistently demonstrate that a significant proportion of PaBV-positive birds, ranging from 15.2% in a Polish study to over 80% in a Thai survey, show no clinical signs or gross lesions of PDD at the time of sampling or necropsy [1, 6]. This phenomenon is not simply a matter of low viral load. As detailed in the antigen distribution study by Wünschmann et al., carrier birds can harbor a high burden of viral antigen in a wide array of tissues, including epithelial cells, which are likely the source of viral shedding into the environment [4].
The molecular basis for this dichotomy between infection and disease likely involves a delicate balance between viral replication and host immune regulation. In birds that develop PDD, the immune response may be dysregulated, leading to an excessive, immunopathological reaction that causes the severe ganglioneuritis. In carrier birds, the immune system may effectively control viral replication within the CNS without triggering a destructive inflammatory cascade, or the virus may be restricted to non-neural tissues where it causes minimal damage. This is supported by the finding that in carrier birds without PDD lesions, viral antigen was found in epithelial cells but was less prominent in neurons of the brainstem and myenteric plexus [4]. The molecular mechanisms governing this immune privilege or tolerance are not fully understood but are likely influenced by host genetics, age at infection, co-infections with other pathogens such as circoviruses or polyomaviruses [6], and the specific genotype of the infecting PaBV strain.
Seasonal Patterns and Environmental Triggers
Emerging evidence suggests that the molecular pathogenesis of PDD may be modulated by external factors, including seasonality. A year-long surveillance study in Taiwan documented a striking seasonal pattern, with peak PaBV infection rates occurring in the spring (68%) and the lowest rates in the summer (25%) [2]. This pattern is reminiscent of other viral diseases where environmental stressors, such as changes in temperature, humidity, photoperiod, and breeding-related stress, can trigger viral reactivation or increased susceptibility. From a molecular perspective, stress hormones like corticosteroids can suppress cell-mediated immunity, potentially allowing a latent or low-level PaBV infection to reactivate, leading to increased viral shedding and a higher risk of transmission. This seasonal fluctuation has significant implications for biosecurity protocols, suggesting that intensified surveillance and quarantine measures may be warranted during spring months in temperate regions.
Implications for Diagnostic and Control Strategies
The molecular pathogenesis of PaBV directly informs diagnostic approaches. The fact that viral shedding can be intermittent and that the virus is not uniformly distributed in all tissues explains why the use of multiple sample types is recommended for accurate diagnosis. Choanal swabs have been identified as the most effective single sample type for detection, but positive cases have been identified exclusively in other specimen types, such as cloacal swabs or tissue biopsies [1]. The detection of viral RNA by RT-PCR remains the gold standard, but the interpretation of a positive result must be nuanced. A positive RT-PCR in a healthy bird does not confirm PDD; it confirms PaBV infection, which may be subclinical. Conversely, a negative RT-PCR from a single swab does not rule out infection, particularly if the bird is in a latent phase. Histopathological examination of full-thickness biopsies of the proventriculus or crop, looking for the characteristic lymphoplasmacytic ganglioneuritis, remains the definitive antemortem diagnostic test for PDD [3, 5]. The molecular understanding of viral persistence and the carrier state also underscores the need for stringent quarantine protocols for any new bird entering a collection, regardless of its clinical appearance. The high prevalence of PaBV in captive populations globally, from Thailand (13.85%) to Taiwan (45.97%) and Brazil (73.7%), highlights the urgent need for standardized international guidelines for monitoring and control, as advocated by the World Organisation for Animal Health (WOAH) for other significant avian pathogens [1, 2, 5].
Global Epidemiology and Genotype Distribution of Psittacine Bornavirus
The global distribution of psittacine bornavirus (PaBV) and its associated disease, proventricular dilatation disease (PDD), represents one of the most significant emerging infectious disease challenges for captive and wild psittacine populations. Since the etiological confirmation of avian bornavirus (ABV) as the causative agent of PDD in 2008, a growing body of molecular epidemiological evidence has delineated a complex viral landscape characterized by multiple genotypes, variable geographical prevalence, and distinct transmission dynamics that collectively shape the global epizootiology of this pathogen. Understanding this distribution is not merely an academic exercise; it is foundational for implementing evidence-based biosecurity protocols, informing international trade regulations, and guiding conservation strategies for threatened and endangered psittacine species.
Prevalence Across Continents and Captive Settings
The prevalence of PaBV infection, as determined by reverse transcription polymerase chain reaction (RT-PCR) and nested PCR assays targeting highly conserved regions such as the nucleoprotein (N) or matrix (M) genes, exhibits remarkable heterogeneity across different geographical regions and captive management systems. Data from recent comprehensive surveillance efforts reveal that PaBV is endemic in captive psittacine populations across Asia, Africa, the Americas, and Europe, though the intensity of circulation varies dramatically.
In Southeast Asia, a landmark molecular survey conducted across five regions of Thailand reported a prevalence of 13.85% (38 of 231 birds) among captive psittacines representing three families (Psittaculidae, Psittacidae, and Cacatuidae) [1]. This study utilized choanal, cloacal, and fecal swabs as well as tissue samples, and importantly, demonstrated that choanal swabs were the most sensitive single sample type for virus detection, yet approximately 15% of positive cases were identified exclusively through analysis of other specimen types, a finding that underscores the critical necessity of multi-site sampling protocols for accurate prevalence estimation [1]. In Taiwan, where the psittacine breeding industry is a significant economic sector, a year-long surveillance program involving 124 psittacine birds documented a substantially higher prevalence of 45.97% (57 birds), with 91.2% of positive birds being adults [2]. This stark contrast in prevalence between neighboring Asian countries could reflect differences in sampling strategies, population densities, biosecurity measures, or circulating viral strains. The Taiwan study further identified a distinct seasonal pattern, with peak PaBV detection rates reaching 68% during the spring season compared to a trough of 25% in summer, a novel observation that implicates environmental or behavioral factors, such as breeding stress, increased flock mixing, or temperature-dependent viral shedding kinetics, in modulating transmission risk [2].
Moving to Europe, a decade-long retrospective analysis of necropsy samples from 210 naturally deceased breeder-owned and pet parrots in Poland (2014–2024) revealed an intermediate prevalence of PaBV RNA of 23.8% (50 birds) [6]. Critically, this study also assessed the prevalence of other significant viral pathogens, beak and feather disease virus (BFDV) and avian polyomavirus (APyV), finding rates of 28% and 31%, respectively, and highlighting a frequent pattern of concurrent infections that likely complicates clinical management and pathogenesis [6]. The Polish data further contextualized the clinical significance of PaBV infection: of the 50 PaBV-positive birds, only 18 (36%) exhibited the characteristic postmortem findings of a dilated proventriculus and gizzard, while 32 birds (15.2% of the total study population) were positive for PaBV RNA in the absence of any gross PDD lesions [6]. This observation is consistent with the widely acknowledged phenomenon of subclinical or asymptomatic carriage.
In South America, the epidemiological picture is perhaps most concerning for conservation biology. An investigation of two distinct breeding facilities in Brazil, one a commercial operation (aviary A) and the other a conservation-minded facility (aviary B), detected PaBV infection in an alarming 73.7% of 38 necropsied psittacines, with 15.8% of the birds belonging to threatened species [5]. The prevalence within aviary A was 88.9% and within aviary B was 69%, indicating widespread intra-facility dissemination [5]. Disease penetrance was high but incomplete; in aviary A, 100% of birds had typical PDD lesions at necropsy, whereas in aviary B, 65.5% of birds exhibited such lesions, and only 27.6% had shown clinical signs prior to death [5]. This suggests that genotype, host species, immune status, and management stressors all contribute to the variable expression of disease. The South African experience provides additional perspective; the first molecular confirmation of PaBV-4 in that country came from three captive bred blue and gold macaws (Ara ararauna) from a single breeding facility, all of which died with acute PDD [3]. The identical sequence of the analyzed genome fragment across all three birds, combined with their young age and shared origin, raises the critical and unresolved question of possible vertical transmission [3].
Genotype Distribution and Phylogeographic Patterns
Contemporary genotyping, which relies on sequencing of the N, M, or X/P genes, has defined at least eight distinct PaBV genotypes circulating in psittacines, but the epidemiological literature consistently identifies PaBV-2 and PaBV-4 as the most prevalent and globally distributed variants. This genotype-level analysis provides crucial insight into transmission pathways, host range, and potential pathogenicity differences.
PaBV-4 has emerged as the dominant genotype across multiple continents. In Thailand, phylogenetic analysis of positive samples classified PaBV-4 as the predominant genotype, which was further subdivided into two distinct intra-genotypic groups, suggesting ongoing viral evolution and diversification within a relatively confined captive population [1]. Similarly, in Brazil, sequencing of the matrix gene fragment from 28 positive birds across both aviaries exclusively identified PaBV-4, indicating that this genotype has achieved a high degree of endemicity in South American captive psittacine populations [5]. The three index cases from South Africa also uniformly yielded PaBV-4, and the consistent sequence identity among those birds, along with their epidemiological linkage, strongly implies a point-source introduction followed by rapid intra-facility spread [3]. In Taiwan, phylogenetic analyses of the X/P gene from three brain samples identified both PaBV-2 and PaBV-4 as co-circulating genotypes, but the limited sampling precludes definitive statements about their relative abundance in that region [2].
The distribution of PaBV-2, while also widespread, appears to be more restricted in its phylogeographic footprint compared to PaBV-4. The Thailand study identified PaBV-2 alongside PaBV-4, and the Taiwan data also documented PaBV-2 [1, 2]. However, genotype 2 has not been reported in the South American or African studies included in this analysis, suggesting that its global dissemination may be more recent or subject to different host or ecological constraints. The first genotype to be molecularly characterized, PaBV-1 (formerly ABV-1), remains an important but comparatively less frequently detected variant. A seminal study from North America documented the association of PaBV-1 with a large outbreak of PDD in a multi-species aviary, where 7 of 10 affected birds presented with clinical signs consistent with PDD, and all seven tested positive for PaBV-1 RNA [4]. Interestingly, the tissue distribution of viral antigen in those birds was largely restricted to neuroectodermal cells (neurons, astroglia, ependymal cells) in birds with clinical PDD, but in two birds without disease, the antigen was widely disseminated in epithelial cells of the alimentary and urogenital tracts, retina, heart, and skeletal muscle [4]. This differential tissue tropism may correlate with genotype-specific pathogenic mechanisms.
The biological basis for the apparent global predominance of PaBV-4 remains speculative but can be examined through several lenses. It is plausible that PaBV-4 possesses a higher replicative fitness, a broader host range, or an enhanced ability to establish persistent, asymptomatic infections with prolonged viral shedding, thereby increasing its transmission efficiency. The World Organisation for Animal Health (WOAH) recognizes bornaviruses as pathogens of significance for the international movement of psittacines, and the genotype-specific prevalence data underscore the need for targeted surveillance protocols. From a conservation perspective, the predominance of PaBV-4 in threatened South American species is particularly alarming [5]. The potential for spillover from heavily infected captive populations into wild, naïve parrot populations, many of which are listed as “Near Threatened” or “Vulnerable” by the International Union for Conservation of Nature (IUCN), represents a genuine epizootiological threat that requires urgent international coordination [1, 5]. The Centers for Disease Control and Prevention (CDC) have historically regulated the importation of psittacines to mitigate the risk of introducing zoonotic pathogens (e.g., Chlamydia psittaci) and other avian diseases, and similar frameworks should be rigorously applied to prevent the transboundary spread of high-risk PaBV genotypes.
Subclinical Infections, Carrier States, and Implications for Transmission
A recurring theme across all global epidemiological studies is the high proportion of PaBV-positive birds that are asymptomatic carriers. This subclinical carrier state has profound implications for transmission dynamics and disease control. In Thailand, 81.58% of PaBV-positive birds were clinically normal at the time of sampling, a finding that aligns with a broader biological understanding of bornavirus persistence [1]. Similarly, the Polish necropsy study found that 64% of PaBV-positive birds lacked any gross pathological evidence of PDD [6]. From an evolutionary perspective, this high rate of asymptomatic infection is logical: a pathogen that rapidly kills its obligate host before transmission can occur is evolutionarily disadvantaged. By establishing a persistent, subclinical infection with intermittent or continuous shedding, PaBV ensures its continued propagation within a flock.
The biological mechanisms underlying this carrier state likely involve the virus’s ability to establish a non-cytolytic, persistent infection in neural cells, where it can avoid immune clearance. The detection of viral RNA in multiple sample types, choanal, cloacal, and fecal, indicates that shedding occurs through multiple routes including respiratory secretions and feces, facilitating both horizontal and potentially fomite transmission [1]. The Taiwan study’s identification of a seasonal peak in spring aligns with the hypothesis that environmental stressors associated with breeding (e.g., elevated cortisol, nutritional demands) may trigger viral reactivation and increased shedding from latently infected carriers [2]. This is a critical insight for management; routine quarantine and testing of new birds are necessary but may fail to detect birds in a low-shedding phase. The challenge is compounded by the fact that, even in facilities with high biosecurity standards, as in the Brazilian conservation facility where prevalence reached 69%, the infection proves extremely difficult to eradicate [5]. The only viable long-term strategy is strict closed-flock management, rigorous all-in/all-out protocols, and sustained molecular surveillance using multi-site sampling protocols validated by studies such as that from Thailand [1, 5]. For regulatory bodies like the United States Department of Agriculture (USDA) and the Animal and Plant Health Inspection Service (APHIS), these data necessitate a re-evaluation of current pre-import and quarantine testing standards for psittacines.
Diagnostic Approaches for Psittacine Bornavirus Detection and PDD Confirmation
The accurate and timely diagnosis of psittacine bornavirus (PaBV) infection and the confirmation of proventricular dilatation disease (PDD) represent one of the most formidable challenges in avian medicine. The complexity arises from the virus’s ability to establish persistent, often subclinical infections, the variable tissue tropism that complicates antemortem sampling, and the imperfect correlation between viral detection and the manifestation of clinical disease. A comprehensive diagnostic strategy must therefore integrate molecular, serological, histopathological, and immunohistochemical modalities, each with distinct strengths and limitations. The following analysis synthesizes the current state of knowledge from global surveillance efforts, emphasizing the biological underpinnings that dictate diagnostic sensitivity and specificity.
Molecular Detection: The Cornerstone of Antemortem Diagnosis
Reverse transcription polymerase chain reaction (RT-PCR) has become the primary tool for detecting PaBV RNA, owing to its high sensitivity and ability to identify viral genotypes. The choice of genetic target is critical; most assays target the nucleoprotein (N) gene or the matrix (M) gene, as these regions are relatively conserved across genotypes while still permitting phylogenetic discrimination [1, 5]. The nested PCR approach, as employed by Suksai et al. (2025) in Thailand, amplifies the N gene and has demonstrated a detection rate of 13.85% among 231 captive psittacines, with 81.58% of positive birds being asymptomatic [1]. This finding underscores a fundamental biological reality: PaBV can establish a carrier state where viral replication occurs at levels detectable by molecular methods without eliciting the classic inflammatory lesions of PDD. The clinical implication is profound, a positive RT-PCR result does not equate to a diagnosis of PDD, but rather indicates infection, which may or may not progress to disease.
The selection of sample type profoundly influences diagnostic yield. Choanal swabs have emerged as the most consistently effective antemortem specimen, likely due to viral shedding from the upper respiratory tract and oropharynx [1]. However, exclusive reliance on a single sample type is a pitfall. Suksai et al. (2025) documented cases where PaBV was detected only in cloacal swabs or fecal samples, not in choanal swabs, suggesting that viral shedding can be intermittent or compartmentalized [1]. This phenomenon is biologically consistent with the virus’s tropism for the myenteric plexus and gastrointestinal epithelium; viral particles may be shed into the intestinal lumen independently of respiratory shedding. For antemortem screening, a minimum of three sample types, choanal swab, cloacal swab, and fresh feces, should be collected on multiple occasions to maximize sensitivity)Skip.
Postmortem molecular diagnosis offers the highest sensitivity, as it allows direct sampling of target organs. The brain, particularly the cerebellum and brainstem, consistently yields the highest viral loads due to the virus’s neurotropic nature [2, 4]. The proventriculus and gizzard are also high-yield tissues, as the myenteric ganglia are primary sites of viral replication and the subsequent lymphoplasmacytic inflammation that defines PDD [3, 5]. In the South African study by Last et al. (2012), RT-PCR of brain and gastrointestinal tissues from three blue and gold macaws confirmed PaBV-4 infection, with identical sequences across all birds suggesting a common source and possible vertical transmission [3]. The Polish surveillance by Szotowska and Ledwoń (2026) provides a sobering perspective: among 210 necropsied parrots, PaBV RNA was detected in 50 birds (23.8%), yet only 22 (10.5%) had gross lesions typical of PDD, and only 18 of those were RT-PCR positive [6]. This means that 32 birds (15.2% of the total) were infected without macroscopic evidence of PDD, reinforcing the concept that molecular detection of the virus is not synonymous with disease confirmation.
Histopathology and Immunohistochemistry: The Gold Standard for PDD Confirmation
While molecular methods detect the virus, histopathological examination of affected tissues remains the definitive means of confirming PDD. The hallmark lesion is lymphoplasmacytic ganglioneuritis, predominantly affecting the myenteric plexus of the proventriculus, ventriculus, and small intestine, often accompanied by similar inflammation in the central and peripheral nervous systems [2-4]. In the Taiwan surveillance by Villanueva et al. (2024), histopathology of birds that succumbed to PDD revealed severe meningoencephalitis in the cerebellum and dilated cardiomyopathy of the heart, indicating that the inflammatory process is not confined to the gastrointestinal tract [2]. The presence of lymphoplasmacytic infiltrates in the adrenal glands, as documented by Wünschmann et al. (2011), further illustrates the systemic nature of the disease [4].
Immunohistochemistry (IHC) using antibodies directed against the viral nucleocapsid (N) protein provides a direct link between histopathological lesions and viral presence. Wünschmann et al. (2011) demonstrated that in birds with clinical PDD, ABV antigen is largely restricted to neuroectodermal cells, neurons, astroglia, ependymal cells of the central nervous system, and neurons of the peripheral nervous system, as well as adrenal cells [4]. The antigen localizes to both the nucleus and cytoplasm of infected cells, a pattern consistent with the nuclear replication phase of bornaviruses. Critically, in two birds that lacked clinical signs and PDD lesions, viral antigen exhibited a more widespread distribution, including epithelial cells of the alimentary and urogenital tracts, retina, heart, skeletal muscle, and skin [4]. This finding suggests that early or subclinical infection may involve a broader cellular tropism, and that the restriction of viral antigen to neural and adrenal tissues may be a consequence of immune-mediated clearance from non-neural sites, or alternatively, that neurotropic strains emerge during disease progression.
The South African study by Last et al. (2012) corroborated these findings, demonstrating positive IHC labeling of neurons, glial cells, myenteric ganglia, nerve fibers, and even smooth muscle cells of the gastrointestinal tract in all three affected macaws [3]. Notably, one bird showed positive labeling of peripheral nerves, indicating that viral antigen can extend beyond the enteric nervous system into somatic nerves, potentially explaining the neurological signs observed in some cases. The combination of histopathology and IHC is therefore indispensable for confirming PDD, as it provides both the morphological evidence of inflammation and the etiological link to PaBV.
Genotyping and Phylogenetic Analysis: Epidemiological and Diagnostic Implications
Molecular detection is not merely a binary positive/negative test; it enables genotyping, which has critical implications for understanding viral diversity, transmission dynamics, and potential differences in pathogenicity. The nucleoprotein (N) gene and matrix (M) gene are the most commonly sequenced targets for phylogenetic analysis [1, 5]. Global surveillance has consistently identified PaBV-2 and PaBV-4 as the predominant genotypes in captive psittacines, with PaBV-4 often being the most prevalent [1, 2, 5]. In Thailand, Suksai et al. (2025) classified PaBV-4 into two distinct groups, suggesting ongoing viral evolution and possibly differential fitness or transmission characteristics [1]. The Taiwan study by Villanueva et al. (2024) sequenced the X/P gene from three brain samples and identified both PaBV-2 and PaBV-4, confirming co-circulation of multiple genotypes within a single geographic region [2].
The clinical relevance of genotype differentiation remains an area of active investigation. While all genotypes can cause PDD, there is emerging evidence that PaBV-4 may be associated with more severe disease or higher prevalence in certain populations. In Brazil, Silva et al. (2020) detected only PaBV-4 in both commercial and conservation breeding facilities, with 73.7% of necropsied birds testing positive and a high proportion showing typical PDD lesions [5]. The South African cases also involved PaBV-4 exclusively [3]. However, genotype 1 has also been documented in birds with classic PDD, as shown by Wünschmann et al. (2011) [4]. The absence of a clear genotype-disease phenotype correlation suggests that host factors, including species susceptibility, immune status, and co-infections, may be more important determinants of disease outcome than viral genotype alone.
From a diagnostic perspective, genotyping is essential for validating RT-PCR assays, as primer mismatches can lead to false negatives if the assay is designed for a genotype not present in the target population. The World Organisation for Animal Health (WOAH) recommends that diagnostic laboratories periodically update their primers based on circulating genotypes. Furthermore, phylogenetic analysis can trace transmission chains within and between facilities, informing biosecurity measures. The identical sequences obtained from three birds in the same South African breeding facility strongly suggested a common source and raised the possibility of vertical transmission, a hypothesis that warrants further investigation [3].
Challenges in Diagnostic Interpretation and the Role of Surveillance
The discordance between viral detection and disease confirmation presents a persistent diagnostic dilemma. In the Polish study, only 36% of birds with confirmed PaBV infection had gross PDD lesions at necropsy [6]. This means that nearly two-thirds of infected birds were asymptomatic carriers or had subclinical infections. The biological basis for this is likely multifactorial: viral load may be below a threshold required to trigger immunopathology, the host’s immune response may be tolerogenic rather than inflammatory, or the virus may be confined to non-neural tissues where it does not elicit ganglioneuritis. The presence of asymptomatic carriers has profound implications for disease control, as these birds can shed virus and perpetuate transmission within aviaries without showing any signs of illness [1, 6].
Seasonal patterns in viral detection add another layer of complexity. The Taiwan surveillance revealed peak PaBV infection rates in spring (68%) and the lowest in summer (25%), suggesting that environmental factors, breeding stress, or seasonal immunosuppression may influence viral reactivation or transmission [2]. Diagnostic sampling strategies should therefore account for temporal variation; a single negative test during summer may not rule out infection that becomes detectable during spring.
The high prevalence of co-infections with other viral pathogens further complicates diagnosis. In the Polish study, 28% of birds were positive for beak and feather disease virus (BFDV) and 31% for avian polyomavirus (APyV) [6]. Co-infections can alter clinical presentation, immunosuppress the host, and potentially affect the sensitivity of molecular assays due to competitive inhibition or sample degradation. A comprehensive diagnostic workup for any psittacine with suspected PDD should include testing for these common co-pathogens, as recommended by the WOAH Terrestrial Manual.
Recommendations for a Comprehensive Diagnostic Protocol
Based on the cumulative evidence from global studies, the following diagnostic approach is recommended for the detection of PaBV and confirmation of PDD:
Antemortem screening: Collect choanal swabs, cloacal swabs, and fresh feces from each bird. Pooled samples may increase sensitivity, but individual sample testing allows identification of shedding patterns. RT-PCR targeting the N or M gene should be performed, with positive results confirmed by sequencing for genotyping. Negative results should be followed by repeat testing at 4-6 week intervals, especially during spring.
Postmortem diagnosis: Collect brain (cerebellum and brainstem), proventriculus, ventriculus, and adrenal glands for RT-PCR and histopathology. Fresh tissue for molecular testing should be frozen at -80°C, while formalin-fixed tissues are suitable for histopathology and IHC.
Histopathology and IHC: Hematoxylin and eosin staining of the proventriculus, ventriculus, and brain is essential to identify lymphoplasmacytic ganglioneuritis and encephalitis. IHC using anti-N protein antibodies should be performed on sections with lesions to confirm the presence of viral antigen.
Genotyping: Sequence a minimum of 400-600 base pairs of the N or M gene for phylogenetic analysis. This information is critical for epidemiological surveillance and for ensuring that diagnostic assays remain current.
Co-infection testing: Screen for BFDV and APyV using PCR or nested PCR, as co-infections are common and may influence clinical outcome [6].
Surveillance programs: Breeding facilities and conservation centers should implement regular surveillance, testing a representative sample of the population at least twice per year, with increased frequency during spring. The International Committee on Taxonomy of Viruses (ICTV) and WOAH provide guidelines for standardized reporting of bornavirus genotypes.
In conclusion, the diagnosis of PaBV infection and confirmation of PDD require a multi-modal approach that integrates molecular detection, histopathological examination, and immunohistochemical confirmation. The high prevalence of asymptomatic carriers, the variability in tissue tropism, and the potential for co-infections demand that clinicians and diagnosticians maintain a high index of suspicion and employ comprehensive sampling strategies. Only through such rigorous diagnostic protocols can we accurately assess the true burden of PaBV infection, implement effective control measures, and ultimately mitigate the impact of PDD on captive psittacine populations worldwide.
Clinical Manifestations and Pathological Features of PDD in Psittacines
Proventricular dilatation disease (PDD) stands as one of the most devastating infectious syndromes affecting captive and free-ranging psittacine birds worldwide, with a pathogenesis intimately linked to infection by parrot bornaviruses (PaBV) [1-4]. First recognized histologically decades before its etiological agent was confirmed in 2008, PDD is characterized by a chronic, progressive, and invariably fatal course in a substantial proportion of infected birds [2, 3, 6]. The clinical presentation reflects a biphasic or overlapping pattern of gastrointestinal and neurological dysfunction, driven by a distinctive lymphoplasmacytic inflammatory assault on the autonomic and central nervous systems [2, 3, 5]. However, the disease exhibits remarkable heterogeneity, ranging from acutely fulminant cases to subclinical carrier states that pose major challenges for diagnosis and control [1, 4, 6]. This section provides an exhaustive, mechanism-grounded analysis of the clinical manifestations and pathological hallmarks of PDD, drawing upon molecular and histopathological evidence from naturally infected psittacine populations across multiple continents and genotypes.
Clinical Manifestations
The clinical spectrum of PDD in psittacines is highly variable, influenced by host species, age, viral genotype, dose, route of infection, and potentially concurrent infections [2, 5, 6]. Gastrointestinal signs are the most frequently reported and classically associated with the disease. The hallmark is proventricular dilatation, a functional stenosis of the distal gastrointestinal tract resulting from damage to the myenteric plexus (ganglioneuritis) [3, 5]. Affected birds present with progressive weight loss despite a normal or increased appetite (polyphagia), undigested seeds in the droppings, regurgitation, and passage of whole seeds or malformed feces [5]. Physical examination may reveal a palpable, fluid-filled, or doughy proventriculus, and auscultation often reveals borborygmi. Vomiting, often projectile, can occur, and abdominal distension may be evident in advanced cases. In one Brazilian study, 66.7% of birds from a commercial aviary exhibited clinical signs, with gastrointestinal manifestations being less frequent than neurological ones, suggesting that the latter may dominate in certain epizootic contexts [5]. Conversely, in a Taiwanese surveillance, severe digestive signs were prominent in birds that subsequently died, with only 8.77% surviving infection overall [2].
Neurological signs, while perhaps underdiagnosed, are equally characteristic and may occur in isolation or accompany gastrointestinal signs. These include ataxia (loss of coordination), paresis or paralysis of the legs or wings, head tremors, torticollis, circling, seizures, and proprioceptive deficits [5]. Blindness due to retinal or optic nerve involvement has also been documented [4]. The neurological manifestations reflect the widespread inflammation of the central nervous system (CNS) and peripheral nerves, particularly the cerebellum, brainstem, and spinal cord [2, 3]. Notably, in the study by Silva et al. (2020), neurological disease was observed more frequently than gastrointestinal disease in South American captive parrots, with many birds presenting with acute onset of incoordination and falling before any digestive upset became apparent [5]. This highlights that PDD should be considered a differential diagnosis for any psittacine with unexplained neurological signs, even in the absence of proventricular dilation.
A critical clinical observation emerging from recent molecular epidemiology is the high prevalence of asymptomatic carriers. In Thailand, 81.58% of PaBV-positive birds were apparently healthy [1]. In Poland, 32 of 50 PaBV-positive birds (64%) lacked any gross PDD lesions at necropsy [6]. In a US-based study by Wünschmann et al. (2011), three of ten case birds from a single aviary had no clinical signs or PDD lesions despite harboring PaBV-1 antigen and RNA [4]. These asymptomatically infected birds are likely reservoirs for viral shedding, and stress, immunosuppression, or co-infections (e.g., with beak and feather disease virus or avian polyomavirus) may trigger progression to clinical disease [6]. The seasonal peak of PaBV infection in spring (68% prevalence vs. 25% in summer) noted in Taiwan [2] may correlate with breeding stress or environmental factors, further underscoring the role of host status in disease expression. Additionally, the presence of PaBV-2 and PaBV-4 genotypes in both symptomatic and asymptomatic birds [1, 2] suggests that viral genotype alone does not dictate clinical outcome; host genetics, immune response, and viral load are likely critical determinants.
Pathological Features
The pathological substrate of PDD is a distinctive, non-suppurative (lymphoplasmacytic) inflammation selectively targeting neural and neuroectodermal tissues, with secondary effects on smooth muscle function. The most consistent and pathognomonic lesion is lymphoplasmacytic ganglioneuritis of the myenteric and submucosal plexuses of the gastrointestinal tract, particularly the proventriculus and gizzard [3, 5]. Histologically, this is characterized by infiltration of lymphocytes, plasma cells, and occasional macrophages into and around the ganglia and nerve fibers, often accompanied by neuronal degeneration, gliosis, and fibrosis in chronic cases [3]. The inflammation leads to functional denervation, loss of peristaltic coordination, and ultimately passive dilatation of the proventriculus and sometimes the gizzard. In the South African study by Last et al. (2012), all three blue-and-gold macaws with fatal PDD exhibited severe myenteric ganglioneuritis and leiomyositis (inflammation of smooth muscle) [3]. Proventricular dilatation was present in 100% of PaBV-positive birds from aviary A and 62% from aviary B in Brazil [5], and in 22 of 210 necropsy cases in Poland (10.5%), though only 18 of these 22 were RT-PCR positive [6]. This discrepancy may reflect post-mortem autolysis, sampling error, or other causes of dilatation.
Beyond the gastrointestinal tract, the central nervous system is consistently affected. Lymphoplasmacytic meningoencephalitis is prominent, especially in the cerebellum, brainstem, and cerebrum [2, 3]. Perivascular cuffing, glial nodules, and neuronal necrosis are common findings. In the Taiwanese study, meningoencephalitis in the cerebellum was a hallmark histopathological change [2]. Immunohistochemistry (IHC) using antibodies against the viral nucleocapsid protein reveals antigen in neurons, astrocytes, ependymal cells, and glial cells of the CNS, as well as in myenteric ganglia and peripheral nerves [3, 4]. Notably, Wünschmann et al. (2011) demonstrated that ABV antigen distribution is broader in subclinical carriers: in two birds without PDD lesions, antigen was found in epithelial cells of the alimentary tract, urogenital tract, retina, heart, skeletal muscle, and skin, tissues not typically positive in clinically affected birds [4]. This suggests that immune containment may restrict viral replication to neuroectodermal cells in symptomatic individuals, while in asymptomatic birds, infection is more widespread yet less destructive. The adrenal gland is also a frequent site of viral antigen and inflammation, potentially contributing to stress-mediated disease exacerbation [4].
Cardiac involvement is increasingly recognized. In the Taiwanese cohort, dilated cardiomyopathy was described in psittacines that succumbed to PDD [2]. Myocardial inflammation and necrosis have been reported sporadically, and given the autonomic innervation of the heart, ganglioneuritis of cardiac plexi may underlie arrhythmias and sudden death. Other extraneural lesions include mild interstitial nephritis, hepatitis, and pancreatitis, though these are considered secondary or incidental [3, 5].
Gross pathology at necropsy is often characteristic: a markedly dilated, thin-walled proventriculus, sometimes distended with ingesta or fluid; a flaccid gizzard; and occasionally splenomegaly or hepatomegaly. The brain may appear grossly normal, but histology is essential for diagnosis, as up to 36% of PaBV-positive birds in Poland had no typical PDD lesions at gross examination [6]. The detection of viral RNA by RT-PCR from brain, proventriculus, or choanal swabs is the gold standard for confirmatory diagnosis, with choanal swabs showing the highest sensitivity among antemortem samples [1]. However, reliance on a single sample type may miss infections, as some cases are positive only in feces or cloacal swabs [1].
The pathological profile across genotypes appears broadly similar. Genotypes 1, 2, and 4, the most commonly reported globally, all induce the characteristic ganglioneuritis and encephalitis [1, 3, 5]. Genotype 4 (PaBV-4) has been documented in Thailand, Brazil, South Africa, and Taiwan [1-3, 5], while genotype 1 was associated with the same lesions in US captive birds [4]. No genotype-specific pathognomonic features have been consistently identified, although subtle differences in tissue tropism or lesion severity may exist and warrant further comparative studies. The World Organisation for Animal Health (WOAH) recognizes PDD as an important disease of psittacines, and while not currently listed as a notifiable disease under the Terrestrial Animal Health Code, its impact on conservation breeding programs (including for IUCN Near Threatened species) and the international pet trade has prompted calls for enhanced surveillance and biosecurity [1, 5]. The Food and Agriculture Organization (FAO) and World Health Organization (WHO) have noted the potential for bornaviruses to cross species barriers, though no zoonotic transmission has been confirmed for PaBV. Nonetheless, the pathological parallels with mammalian bornaviruses (e.g., Borna disease virus in horses and sheep) underscore the need for a One Health approach in understanding these emerging neurotropic pathogens.
In summary, the clinical manifestations of PDD range from classic gastrointestinal and neurological signs to completely asymptomatic infection, while the pathological features are dominated by lymphoplasmacytic ganglioneuritis of the gut and meningoencephalitis, with immunohistochemical evidence of viral antigen in neuroectodermal cells. The coexistence of viral RNA in tissues without lesions in a substantial proportion of birds [4, 6] indicates that viral infection alone is insufficient to cause disease, implicating host immune factors, viral load, and possible co-pathogens in pathogenesis. The high prevalence of asymptomatic carriers in multiple global regions [1, 6] presents a formidable obstacle to eradication, and regular molecular surveillance using multiple sample types is essential for both clinical management and conservation efforts [1, 2, 5].
Evolutionary Dynamics and Phylogenetic Characterization of PaBV Genotypes
The genomic architecture and evolutionary trajectory of psittacine bornaviruses (PaBVs) represent a complex interplay between viral adaptation, host ecology, and anthropogenic factors that collectively shape the global distribution of these neurotropic pathogens. The family Bornaviridae, within the order Mononegavirales, comprises non-segmented, negative-sense RNA viruses characterized by a high degree of genetic conservation relative to other RNA viruses, yet the eight recognized PaBV genotypes (PaBV-1 through PaBV-8) exhibit distinct phylogenetic clustering that reflects both historical divergence and contemporary selective pressures. Understanding these evolutionary dynamics is not merely an academic exercise; it is foundational to predicting emergent variants, designing molecular diagnostics, and implementing evidence-based quarantine protocols for captive psittacine populations worldwide.
The Phylogenetic Landscape of PaBV Genotypes: A Global Mosaic
Phylogenetic analyses based on conserved genomic regions, particularly the nucleoprotein (N) gene, the matrix (M) protein gene, and the phosphoprotein (X) gene, have consistently resolved PaBV isolates into well-supported clades corresponding to specific genotypes. The N gene, owing to its relative conservation and essential role in viral replication, has been the primary target for molecular surveillance and genotyping efforts across diverse geographic regions [1, 2, 5]. However, the X/P gene region has also proven valuable for fine-scale phylogenetic discrimination, particularly in distinguishing between closely related genotypes such as PaBV-2 and PaBV-4 [2].
The phylogenetic data amassed over the past two decades reveal a striking pattern: PaBV-4 has emerged as the most globally ubiquitous genotype, having been documented in captive psittacine populations across Asia, Africa, South America, and Europe [1, 3, 5]. This near-cosmopolitan distribution contrasts with the more geographically restricted or less frequently detected genotypes. For instance, PaBV-2, while also reported in multiple continents including Asia [1, 2], appears to circulate at lower prevalence levels in most surveyed populations. The predominance of PaBV-4 raises fundamental questions regarding its evolutionary fitness: does this genotype possess enhanced transmissibility, broader host range, or superior ability to establish persistent, asymptomatic infections that facilitate undetected spread?
Recent work in Thailand has provided granular insight into PaBV-4 sub-structure. Suksai et al. (2025) demonstrated that PaBV-4 sequences from captive birds could be further classified into two distinct phylogenetic groups, suggesting ongoing diversification and possibly the existence of multiple co-circulating lineages within a single geographic region [1]. The biological significance of this intra-genotypic variation remains to be fully elucidated, but it may correlate with differences in tissue tropism, pathogenicity, or host species susceptibility. Critically, the detection of both PaBV-2 and PaBV-4 within the same sampling cohort in Thailand, Taiwan, and South Africa underscores the reality of multi-genotype co-circulation in captive facilities, a phenomenon that creates opportunities for co-infection and, theoretically, for recombination events that could generate novel viral chimeras [1-3].
Substitution Rates, Selective Pressures, and Molecular Clocks
Bornaviruses, as negative-sense RNA viruses, lack the proofreading capacity of DNA polymerases and are therefore subject to mutational accumulation over time. However, the substitution rate of bornaviruses is notably lower than that of many other RNA viruses, such as influenza A virus or HIV-1, likely reflecting constraints imposed by their highly structured genome and the need to maintain critical protein-protein interactions. This slower evolutionary rate has implications for phylogenetic inference: it means that genotype-level distinctions are likely to represent relatively ancient divergence events, whereas contemporary outbreaks may be characterized by near-identical sequences that indicate recent common ancestry and rapid transmission.
The detection of identical or nearly identical PaBV-4 sequences among birds from the same breeding facility, as reported by Last et al. (2012) in South Africa, is highly suggestive of a point-source introduction followed by local spread, potentially involving vertical transmission from parent to offspring [3]. The authors observed that all three affected blue and gold macaws originated from the same facility and were young at presentation, raising the possibility that viral transmission occurred either in ovo or via close postnatal contact. This observation aligns with the histopathological detection of viral antigen in reproductive tissues of some infected birds, as documented by Wünschmann et al. (2011) in their study of PaBV-1 (genotype 1) infection, where viral antigen was present in epithelial cells of the urogenital tract [4]. The possibility of vertical transmission introduces a profound challenge for disease control: if infection can be passed from parent to offspring without the need for horizontal spread, then even rigorous biosecurity measures that isolate apparently healthy adults may fail to eliminate the virus from a breeding population.
Selective pressure analyses on PaBV genomes have focused primarily on the surface glycoprotein (G) and the accessory X protein, both of which are exposed to host immune surveillance. The G protein mediates viral entry into host cells and is a primary target of neutralizing antibodies; thus, it is expected to experience positive selection in response to host immune pressure. Conversely, the N protein, which is involved in viral replication and is highly conserved, typically experiences purifying selection that removes deleterious mutations. The balance between these opposing forces shapes the evolutionary trajectory of PaBV lineages and determines the rate at which antigenic variants may arise. To date, no evidence of antigenic drift sufficient to render current diagnostic assays ineffective has emerged, but ongoing surveillance remains essential.
Geographic Structuring and Phylogeographic Patterns
The phylogeographic analysis of PaBV reveals a complex pattern that reflects both historical viral dissemination, likely mediated by the international pet trade, and more recent, localized circulation within captive populations. The detection of PaBV-4 on four continents (Asia, Africa, South America, and Europe) in captive birds indicates that this genotype has been successfully transported across biogeographic barriers, probably through the movement of asymptomatically infected individuals [1, 3, 5, 6]. Indeed, the high proportion of subclinical carriers documented in multiple studies, 81.58% in Thailand [1], and 64% of PaBV-positive birds in Poland lacking typical PDD lesions at necropsy [6], highlights the existence of a cryptic viral reservoir that can sustain transmission chains without triggering clinical suspicion.
Within South America, the situation is particularly concerning from a conservation perspective. Silva et al. (2020) documented PaBV-4 infection in Brazilian captive parrots, including species classified as threatened, such as the Spix’s macaw (Cyanopsitta spixii) and the blue-winged macaw (Primolius maracana) [5]. The proximity of infected captive populations to remaining wild habitats raises the specter of spillover, a risk explicitly noted by Suksai et al. (2025) in the Thai context, where several native psittacine species are listed as “Near Threatened” by the IUCN [1]. The potential introduction of PaBV into naïve wild populations could have catastrophic consequences, as these birds would lack any prior immunological experience with the virus and may suffer high mortality rates. The World Organisation for Animal Health (WOAH) has recognized the importance of bornavirus surveillance in captive birds, but specific guidelines for preventing spillover into wild populations remain underdeveloped.
Seasonal patterns in infection prevalence, as documented by Villanueva et al. (2024) in Taiwan, add another layer of complexity to the evolutionary dynamics of PaBV. The authors observed a striking seasonal fluctuation, with peak infection rates of 68% occurring in spring and a nadir of 25% in summer [2]. While the mechanisms underlying this pattern are not fully understood, several hypotheses warrant investigation. First, spring coincides with the breeding season for many psittacine species, and the physiological stress associated with reproduction, including hormonal changes, increased metabolic demands, and the immunosuppressive effects of corticosterone, may reactivate latent viral infections in carrier birds, leading to increased shedding and transmission. Second, seasonal changes in housing conditions, such as increased ventilation in summer or crowding during winter months, could influence transmission dynamics. Third, the survival and infectivity of PaBV particles in the environment may be influenced by temperature and humidity, although data on environmental stability of bornaviruses are scarce. The identification of a seasonal pattern has practical implications: diagnostic surveillance efforts may be most productive if concentrated during spring months, and quarantine periods for newly introduced birds should account for the possibility of seasonal reactivation.
Implications of Co-Infection and Multi-Genotype Circulation
The phenomenon of co-infection with multiple PaBV genotypes, or with other viral pathogens such as beak and feather disease virus (BFDV) and avian polyomavirus (APyV), introduces additional evolutionary complexity. Szotowska and Ledwoń (2026) reported that 23.8% of necropsied parrots in Poland were PaBV-positive, while 28% harbored BFDV and 31% carried APyV [6]. Although the study did not specifically quantify the proportion of birds with dual or triple infections, the high individual prevalence rates suggest that co-infections are likely common. From an evolutionary perspective, co-infection provides the substrate for viral recombination, a process in which fragments of the genome from two different viruses are reassembled into a single progeny genome. While recombination has not been definitively documented in natural PaBV infections, it is theoretically possible given the segmented-like replication strategy of bornaviruses (which use a unique "copy-back" mechanism for generating defective interfering genomes). The detection of two distinct PaBV-4 groups in Thailand [1] raises the possibility that divergent lineages are co-circulating within the same facility, creating opportunities for genetic exchange.
Moreover, co-infection with immunosuppressive viruses such as BFDV may modulate the host's ability to control PaBV replication, potentially leading to higher viral loads, increased shedding, and accelerated evolution through relaxed purifying selection. The interplay between these pathogens is poorly understood but represents a critical knowledge gap. From a diagnostic standpoint, the presence of BFDV or APyV should not distract clinicians from testing for PaBV, as the concurrent presence of multiple viruses may complicate clinical interpretation and necessitate multiplex molecular assays.
Diagnostic and Surveillance Implications of Phylogenetic Diversity
The phylogenetic characterization of PaBV genotypes has direct, practical consequences for molecular diagnostics. Nested PCR assays targeting the N gene, while broadly effective, may exhibit differential sensitivity across genotypes if primer binding sites contain sequence mismatches. The demonstration by Suksai et al. (2025) that choanal swabs were the most effective single sample type for detecting PaBV RNA, but that some positive cases were identified exclusively in other specimen types (e.g., cloacal swabs or tissue samples), underscores the importance of sample collection strategy [1]. This observation may reflect genotype-specific differences in tissue tropism or shedding patterns. For instance, Wünschmann et al. (2011) demonstrated that PaBV-1 (genotype 1) antigen distribution in asymptomatic carrier birds was broader than in birds with clinical PDD, extending to epithelial cells of the alimentary and urogenital tracts, retina, heart, skeletal muscle, and skin [4]. If PaBV-4 exhibits a similarly wide tissue distribution in asymptomatic carriers, then reliance on a single sample type (e.g., choanal swab) may miss a substantial proportion of infections.
The need for diagnostic assays that can reliably detect all eight known PaBV genotypes, including those that may be emerging in unsampled populations, is urgent. Real-time RT-PCR assays targeting highly conserved regions of the N or M genes, combined with degenerate primers or probes that accommodate known sequence variation, represent the current standard. Sequencing of positive amplicons should be performed whenever possible to confirm genotype identity and to contribute to the growing global dataset of PaBV sequences. Such data are essential for phylodynamic analyses that can reveal transmission networks, identify source populations, and track the movement of viruses across international borders, activities that align with the goals of the Centers for Disease Control and Prevention (CDC) and other public health authorities in monitoring emerging zoonotic and agricultural pathogens.
The evolutionary dynamics of PaBV genotypes are thus a product of viral biology, host ecology, and human intervention. The global dominance of PaBV-4, the existence of subclinical carriers, the potential for vertical transmission, and the risk of spillover into wild populations all underscore the need for sustained, internationally coordinated surveillance efforts. Without such efforts, the phylogenetic characterization of PaBV will remain incomplete, and the capacity to predict and prevent future outbreaks will be severely compromised.
Transmission Dynamics, Carrier States, and Risk Factors for PaBV Infection
The elucidation of transmission dynamics for parrot bornavirus (PaBV) remains one of the most pressing challenges in psittacine medicine, as the virus’s capacity for silent dissemination within captive populations fundamentally undermines control efforts. Unlike many acute viral pathogens that produce predictable epizootic patterns, PaBV exhibits a complex epidemiological profile characterized by prolonged incubation periods, a high prevalence of subclinical infections, and multiple potential routes of viral shedding. Understanding these dynamics is not merely an academic exercise; it is the cornerstone upon which effective biosecurity protocols, quarantine strategies, and conservation programs for threatened psittacine species must be built.
Horizontal Transmission Pathways and Environmental Persistence
The predominant mode of PaBV transmission is widely accepted to be horizontal, occurring through direct contact between infected and susceptible birds, as well as through indirect exposure to contaminated fomites and environments. The virus is shed in high concentrations in the feces of infected birds, and the fecal-oral route is considered the primary mechanism of spread within aviaries and breeding facilities [1, 2]. This is supported by the detection of viral RNA in cloacal swabs and fecal samples from both clinically ill and asymptomatic carriers [1, 6]. The implications for captive management are profound: shared feeding stations, communal water sources, and even the substrate of aviary floors can become reservoirs of infectious virus. The work of Suksai et al. (2025) in Thailand demonstrated that choanal swabs were the most effective single sample type for detection, yet a proportion of positive cases were identified exclusively through other specimen types, including cloacal swabs and tissue samples [1]. This finding underscores the necessity of utilizing multiple sample types for accurate diagnosis and highlights the multifaceted nature of viral shedding, which likely involves both respiratory and gastrointestinal routes.
The potential for respiratory transmission, while less definitively characterized than fecal-oral spread, cannot be discounted. The detection of PaBV RNA in choanal swabs suggests that viral particles may be present in respiratory secretions [1]. Given the neurotropic nature of bornaviruses and their ability to infect epithelial cells of the respiratory tract in some cases, aerosolized virus could contribute to rapid spread within densely stocked aviaries. Furthermore, the seasonal pattern of PaBV infections observed in Taiwan, with peak prevalence in spring (68%) and a nadir in summer (25%), raises intriguing questions about environmental and physiological factors that modulate transmission [2]. Spring coincides with the breeding season for many psittacine species, a period of heightened physiological stress, increased contact between birds, and the introduction of naive chicks into the population. It is plausible that stress-induced immunosuppression during breeding facilitates viral reactivation and shedding in latently infected carriers, thereby amplifying transmission during this period. This seasonal cyclicity is reminiscent of other viral infections where host stress and environmental conditions converge to drive epizootic waves.
The Carrier State: A Silent Reservoir of Infection
Perhaps the most formidable obstacle to PaBV control is the existence of a robust and widespread carrier state. A substantial proportion of PaBV-infected birds exhibit no clinical signs of proventricular dilatation disease (PDD), yet they actively shed virus and serve as cryptic reservoirs for ongoing transmission. The data from multiple geographic regions are remarkably consistent on this point. In Thailand, Suksai et al. (2025) reported that 81.58% of PaBV-positive birds were asymptomatic at the time of sampling [1]. Similarly, in Poland, Szotowska and Ledwoń (2026) found that 32 of 50 PaBV-positive birds (64%) lacked the gross pathological lesions typical of PDD at necropsy [6]. These findings are not anomalies; they represent a fundamental characteristic of PaBV biology. The virus establishes a persistent infection, likely within cells of the central and peripheral nervous systems, where it can evade immune clearance and remain transcriptionally active at low levels for extended periods [4].
The biological mechanisms underpinning this carrier state are illuminated by immunohistochemical studies. Wünschmann et al. (2011) demonstrated that in birds without clinical signs or lesions of PDD, viral antigen exhibited a remarkably widespread distribution, including epithelial cells of the alimentary and urogenital tracts, retina, heart, skeletal muscle, and skin, in addition to the expected neuroectodermal cells [4]. This contrasts sharply with birds showing clinical PDD, where viral antigen was largely restricted to neuroectodermal cells (neurons, astroglia, ependymal cells) and adrenal cells [4]. This differential tissue tropism suggests that the carrier state may be characterized by active viral replication in peripheral tissues, including those involved in shedding (e.g., gastrointestinal epithelium), while the development of clinical disease may require a shift toward neurotropism and the induction of immunopathological damage in the central and enteric nervous systems. The presence of viral antigen in the skin and urogenital tract of asymptomatic carriers also raises the possibility of additional, underappreciated routes of transmission, such as through feather dust or reproductive secretions [4].
The existence of this silent reservoir has profound implications for diagnostic strategies and population management. A single negative test, particularly from a single sample type, cannot rule out infection. The work of Silva et al. (2020) in Brazil, where PaBV infection was detected in 73.7% of birds from two breeding facilities, highlights how deeply entrenched the virus can become in captive populations, even in the absence of widespread clinical disease [5]. In aviary B (a conservationist facility), only 27.6% of birds showed clinical signs, yet 69% were PaBV-positive, and 65.5% had typical PDD lesions at necropsy [5]. This disconnect between clinical presentation and infection status is a hallmark of PaBV epidemiology and necessitates a shift from reactive diagnosis (testing only sick birds) to proactive, population-level surveillance.
Risk Factors: Species Susceptibility, Age, and Management Practices
The risk of PaBV infection and subsequent progression to PDD is not uniform across psittacine populations. A complex interplay of host, viral, and environmental factors determines the outcome of exposure. While PaBV can infect a wide range of psittacine species, there is evidence suggesting differential susceptibility. The genotype distribution itself may influence pathogenesis; PaBV-4 has emerged as the predominant genotype in multiple studies, including those from Thailand [1], Taiwan [2], South Africa [3], and Brazil [5], and has been associated with severe histopathological lesions such as lymphoplasmacytic encephalitis, myenteric ganglioneuritis, and dilated cardiomyopathy [2, 3]. However, the presence of PaBV-2 in both Thailand and Taiwan indicates that multiple genotypes co-circulate and may have different pathogenic potentials [1, 2].
Age appears to be a significant risk factor, though the relationship is nuanced. Villanueva et al. (2024) in Taiwan found that most PaBV infections occurred in adult birds, with a very low survival rate (8.77%) among those that developed clinical disease [2]. This suggests that while adults are more likely to be infected (perhaps due to longer cumulative exposure), they are also more likely to succumb to PDD once clinical signs manifest. Conversely, the detection of PaBV in young birds, particularly the three juvenile blue and gold macaws described by Last et al. (2012) in South Africa, raises the specter of vertical transmission [3]. These birds, all from the same breeding facility and of identical viral sequence, presented with PDD at a young age, a pattern consistent with in ovo or neonatal infection. If vertical transmission is confirmed, it would represent a critical risk factor for the perpetuation of infection within breeding lines, as infected chicks could be born already carrying the virus and begin shedding early in life.
Management practices within breeding facilities are arguably the most modifiable risk factors. The work of Silva et al. (2020) provides a stark comparison between two facilities in Brazil. In aviary A (a commercial facility), 88.9% of birds were PaBV-positive, 100% had typical PDD lesions, and 66.7% showed clinical signs [5]. In aviary B (a conservationist facility), the prevalence was lower (69%), and clinical signs were less frequent (27.6%) [5]. While the exact management differences were not fully detailed, the disparity suggests that factors such as stocking density, hygiene protocols, quarantine procedures for new arrivals, and the segregation of age groups can profoundly influence transmission dynamics. High-density housing, common in commercial operations, facilitates rapid horizontal spread, while conservation facilities with lower densities and more rigorous biosecurity may slow transmission but still struggle to eliminate the virus once it is introduced. The presence of threatened species (15.8% of birds in the Brazilian study) in these facilities underscores the conservation urgency [5]. An outbreak of PaBV in a captive breeding program for a critically endangered macaw or conure could be catastrophic, potentially decimating years of conservation effort.
Finally, the role of co-infections as risk factors for PaBV transmission or disease progression warrants consideration. Szotowska and Ledwoń (2026) in Poland found that while PaBV was detected in 23.8% of necropsied parrots, co-infections with beak and feather disease virus (BFDV, 28%) and avian polyomavirus (APyV, 31%) were even more common [6]. The immunosuppressive effects of BFDV, in particular, could predispose birds to PaBV infection or reactivation of latent virus, creating a synergistic dynamic that amplifies viral shedding and disease severity. The high prevalence of these co-infections in the same populations suggests that comprehensive viral surveillance, rather than single-pathogen testing, is essential for understanding the full epidemiological picture. The World Organisation for Animal Health (WOAH) has recognized the significance of bornavirus infections in psittacines, and the patterns observed globally, from Asia to the Americas to Europe, underscore the need for internationally harmonized surveillance and biosecurity standards to mitigate the risk of spillover into already vulnerable wild populations [1, 5].
Prevention, Biosecurity, and Conservation Implications of Psittacine Bornavirus
The management of Psittacine Bornavirus (PaBV) and its associated pathology, Proventricular Dilatation Disease (PDD), presents a multifaceted challenge that extends beyond clinical veterinary medicine into the realms of avicultural biosecurity, wildlife conservation, and international trade regulation. The unique biological characteristics of this pathogen, namely, its ability to establish persistent, subclinical infections in a significant proportion of the avian population, profoundly complicate the development and implementation of effective control strategies [1, 4, 6]. Consequently, a comprehensive approach to prevention and biosecurity must be grounded in a deep understanding of viral transmission dynamics, diagnostic limitations, and host–pathogen interactions. Furthermore, the detection of PaBV in captive populations situated within or near the endemic ranges of threatened psittacine species introduces a critical dimension of conservation biology, where captive management failures could have cascading ecological repercussions [1, 5].
The Fundamental Challenge: Asymptomatic Carriers and Diagnostic Gaps in Biosecurity
A primary obstacle to the eradication of PaBV from captive collections is the high prevalence of asymptomatic carriers. Data from diverse geographic regions, including Thailand, Brazil, and Poland, consistently demonstrate that a substantial fraction of PaBV-infected birds exhibit no clinical signs of PDD at the time of sampling or necropsy [1, 5, 6]. In a study from Thailand, 81.58% of PCR-positive birds were asymptomatic, a finding that underscores the existence of a robust carrier state where the virus is shed without precipitating the characteristic lymphoplasmacytic ganglioneuritis of the gastrointestinal tract [1]. Similarly, investigations in Poland revealed that 64% of birds with confirmed PaBV infections lacked the gross pathological lesions of a dilated proventriculus or gizzard at necropsy [6]. This phenomenon is not merely an epidemiological curiosity; it has profound implications for biosecurity. These outwardly healthy birds function as cryptic reservoirs, capable of disseminating virus into the environment and to naive cohorts during breeding, trading, or exhibition, even as facilities believe they are disease-free [1, 5].
The pathobiology of this carrier state, as elucidated by antigen distribution studies, provides a mechanistic explanation for this diagnostic challenge. In birds that succumb to PDD, viral antigen is largely restricted to neuroectodermal cells, including neurons and glia of the central and peripheral nervous systems [4]. However, in birds that lack clinical signs and lesions, the viral antigen distribution is markedly more widespread, including the nuclei and cytoplasm of epithelial cells of the alimentary tract, urogenital system, retina, and even skin [4]. This systemic spread in subclinical carriers suggests that viral shedding into the environment, via feces, urine, or epidermal debris, may be more pronounced from these individuals than from terminally ill birds whose viral replication is sequestered in neural tissue. This paradox necessitates a reevaluation of standard sentinel screening protocols.
Current diagnostic strategies, while sensitive, are not infallible. The recommendation for using multiple sample types, particularly the inclusion of choanal swabs alongside fecal or cloacal samples, is critical [1]. As demonstrated in the Thai study, while choanal swabs were the most effective single sample type, exclusive reliance on this method would have missed some positive birds identified via other specimens [1]. A robust biosecurity program must therefore mandate multi-site sampling for any individual being introduced into a naive collection. Furthermore, the detection of viral RNA via RT-PCR does not differentiate between infectious virus and non-infectious nucleic acid fragments, nor does it confirm active replication versus latent carriage. The development and validation of assays for anti-PaBV antibodies could complement PCR screening to identify birds that have been exposed and cleared the infection, or those entering a low-replication phase, thereby providing a more complete epidemiological picture for quarantine decision-making.
Facility-Level Biosecurity: Quarantine, Segregation, and Environmental Management
The implementation of rigorous, facility-level biosecurity protocols is the cornerstone of preventing PaBV introduction and spread. Given the virus’s demonstrated presence in aviaries of all sizes, from commercial breeding operations in Brazil to conservationist centers and small private collections in Europe and Asia, no management system can be considered inherently safe [2, 5]. The minimum standard for any facility acquiring new birds must be a strict quarantine period of no less than 30–60 days, during which individuals are isolated in a separate airspace and handled only after care for existing residents. During quarantine, birds should undergo at least two rounds of RT-PCR testing on multiple sample types, separated by a minimum of 4–6 weeks, to account for the possibility of transient, low-level shedding or a window period between exposure and detectable viremia [1, 2].
The high prevalence rates observed in endemic settings, 45.97% in Taiwan and 73.7% in a Brazilian commercial facility, indicate that once PaBV is established within a collection, control becomes exceedingly difficult [2, 5]. In the Brazilian study, viral RNA was detected in 88.9% of birds from one facility and 69% from another, with genotyping revealing a single dominant genotype (PaBV-4) in both locations, suggesting intra-facility circulation rather than multiple independent introductions [5]. This highlights the need for cohort segregation. Facilities should be divided into discrete biosecure compartments based on age (juveniles versus adults), origin (quarantined versus resident), and health status. The movement of birds between these compartments should be unidirectional or prohibited entirely. Shared equipment, including food bowls, water dispensers, and enrichment items, must be disinfected between uses or dedicated to specific compartments, as fomite transmission is a plausible route given the environmental persistence of bornaviruses.
While specific data on the environmental stability of PaBV outside the host are limited relative to other pathogens (e.g., polyomaviruses or circoviruses), the detection of viral RNA in various tissue types, including skin and epithelia of subclinical carriers, suggests that the virus can be shed into the environment [4]. Standard disinfection protocols using quaternary ammonium compounds, 1% sodium hypochlorite, or accelerated hydrogen peroxide are presumed effective against enveloped viruses, and their rigorous application to surfaces, perches, and nest boxes is essential. The role of ancillary vectors, such as insects or arthropods, in mechanical transmission remains unexplored but warrants consideration in outdoor aviaries. Furthermore, the potential for aerosol transmission, while not definitively proven, cannot be dismissed given the detection of PaBV in choanal swabs and the high density of birds in typical captive settings. Therefore, adequate ventilation and reduced stocking density are prudent biosecurity measures.
Seasonal Patterns and Targeted Surveillance Windows
Emerging epidemiological evidence suggests that PaBV transmission dynamics may exhibit seasonal periodicity, a factor that can be leveraged to optimize surveillance and preventive interventions. A comprehensive year-long surveillance study in Taiwan identified a distinct seasonal pattern, with infection rates peaking in the spring at 68% and reaching a nadir in the summer at 25% [2]. This seasonality may be linked to breeding-related stress, hormonal changes that reactivate latent infections, or environmental factors such as temperature and humidity that influence viral persistence or host immunity. From a biosecurity perspective, the spring peak represents a critical window of heightened risk. Breeding facilities should intensify testing protocols during this period, particularly for parent birds and newly hatched chicks. The low summer rate, conversely, may offer a safer window for introductions or movements of birds between collections after thorough, repeated testing.
The seasonality observation also has implications for the interpretation of prevalence surveys. Single-time-point surveys, such as those conducted in Thailand (13.85% prevalence) or Poland (23.8% prevalence), may underrepresent the true annual infection rate if sampling occurred during a low-transmission season [1, 6]. Biosecurity plans should therefore be dynamic, with testing frequency adjusted according to the calendar and the reproductive cycle of the flock. Additionally, the spring surge may correlate with the age at which birds are most commonly infected. In Taiwan, the majority of PaBV-positive birds were adults, which may reflect cumulative exposure rather than age-related susceptibility [2]. However, the finding of PaBV-4 in young birds from the same breeding facility in South Africa raises the specter of vertical transmission, which would fundamentally alter targeted prevention strategies [3]. If PaBV can be transmitted from parent to offspring in ovo or via crop secretions, then complete reliance on testing and isolating adults will be insufficient; the entire production cycle, from egg to fledgling, must be monitored.
Conservation Implications: The Threat of Spillover into Wild Populations
Perhaps the most alarming and ecologically consequential dimension of PaBV control concerns its potential to spill over from captive reservoirs into vulnerable wild psittacine populations. This risk is particularly acute in regions of high psittacine biodiversity, such as South America, Africa, Southeast Asia, and Australia, where numerous species are already under pressure from habitat loss, the illegal pet trade, and climate change [1, 5]. The presence of PaBV in captive breeding facilities that are ostensibly dedicated to conservation, as documented in the Brazilian study involving a conservationist aviary, represents a profound biosecurity failure that could inadvertently undermine the very mission of species preservation [5].
In the Brazilian study, 15.8% of the birds examined were classified as threatened species, including several native to South America [5]. The detection of PaBV-4 in these individuals, coupled with the high intra-facility prevalence (69% in the conservationist aviary), indicates that these facilities are not sanctuaries from disease but rather amplifiers of a novel pathogen to which wild populations may have no prior immunity [5]. Should an infected captive bird escape, be released in an ill-conceived rehabilitation effort, or be traded illegally, it could introduce PaBV into naive wild flocks. The potential consequences are catastrophic: PDD is nearly 100% fatal in susceptible birds, and a novel disease outbreak could drive a small, isolated population to extinction. The IUCN listing of several affected species as “Near Threatened” in the Thai study underscores the urgency of this threat [1].
The conservation implications extend beyond direct mortality. Subclinical carriers in the wild could serve as long-term reservoirs, maintaining the virus in ecosystems and complicating future recovery efforts. Furthermore, the stress of disease may reduce reproductive success, foraging efficiency, or social dominance, further imperiling already fragile populations. The standard management recommendation for conservation breeding centers must be the complete eradication of PaBV from the captive pool. This requires a multi-pronged approach: 1) strict quarantine and testing of all founder birds before they enter the breeding program; 2) closed colony management with no new introductions unless proven PaBV-free over multiple test cycles; 3) culling or permanent isolation of positive birds to break the transmission chain; and 4) environmental decontamination of facilities that housed infected birds. The challenge is particularly acute in facilities with high existing prevalence, where depopulation and repopulation with known negative stock may be the only viable path to freedom from infection, a decision that carries significant ethical and economic weight.
Policy Gaps and the Need for International Standards
Currently, no universal international standard exists for PaBV testing and certification for the movement of psittacine birds between countries or even between facilities within a nation. While organizations such as the World Organisation for Animal Health (WOAH) have established guidelines for other avian pathogens like Newcastle disease virus and Highly Pathogenic Avian Influenza, PaBV, despite its devastating impact on psittacines, remains largely unregulated. This regulatory vacuum facilitates the silent international spread of the virus through the legal and illegal pet trade. A captive-bred parrot from a facility in Taiwan, Brazil, or Thailand, if not tested, could carry PaBV to a naive aviary in Europe, North America, or elsewhere, seeding a new outbreak [1, 2, 5].
The call from researchers in Brazil for a “national regulatory and health standard for breeding psittacine birds” is a critical step, but the problem is inherently global [5]. A harmonized framework, perhaps modeled on the WOAH Terrestrial Animal Health Code, should mandate pre-export testing for PaBV (using validated RT-PCR protocols on multiple sample types) and include provisions for post-arrival quarantine. Furthermore, transparency in reporting PaBV prevalence from different regions, as facilitated by the studies from Thailand [1], Taiwan [2], and Poland [6], is essential for risk assessment. Countries with endemic circulation should be identified, and importers should adjust their biosecurity requirements accordingly. The veterinary community must also advocate for the inclusion of PaBV in formal disease surveillance systems, which would provide the data infrastructure needed to track its global distribution and evolution, ultimately informing targeted prevention strategies.
In summary, the prevention of PaBV requires a proactive, multi-layered defense that acknowledges the viral biology of persistence and shedding, leverages temporal patterns in transmission, and imposes uncompromising biosecurity at the facility level. Without such measures, the virus will continue to circulate in captivity, with the ever-present risk of escaping into already-imperiled wild populations, thereby compounding the global conservation crisis facing psittacine birds. The integration of molecular diagnostics, strict quarantine protocols, and policy reform is not merely an avicultural best practice but a critical component of species conservation.
References
[1] Suksai P, Sanyathitiseree P, Phatthanakunanan S, Dittawong P, Meetipit P, Kongmadee P, et al.. Molecular detection and genetic characterization of parrot bornavirus in captive psittacine birds in Thailand. Journal of Veterinary Medical Science. 2025. DOI: https://doi.org/10.1292/jvms.25-0232
[2] Villanueva BHA, Chen J, Lin P, Minh H, Le VP, Tyan Y, et al.. Surveillance of Parrot Bornavirus in Taiwan Captive Psittaciformes. Viruses. 2024. DOI: https://doi.org/10.3390/v16050805
[3] Last R, Weissenböck H, Nedorost N, Shivaprasad H. Avian bornavirus genotype 4 recovered from naturally infected psittacine birds with proventricular dilatation disease in South Africa.. Journal of the South African Veterinary Association. 2012. DOI: https://doi.org/10.4102/jsava.v83i1.938
[4] Wünschmann A, Wünschmann A, Honkavuori K, Honkavuori K, Briese T, Briese T, et al.. Antigen tissue distribution of Avian bornavirus (ABV) in psittacine birds with natural spontaneous proventricular dilatation disease and ABV genotype 1 infection. Journal of Veterinary Diagnostic Investigation. 2011. DOI: https://doi.org/10.1177/1040638711408279
[5] Silva AS, Raso T, Costa E, Gómez SYM, Martins N. Parrot bornavirus in naturally infected Brazilian captive parrots: Challenges in viral spread control. PLoS ONE. 2020. DOI: https://doi.org/10.1371/journal.pone.0232342
[6] Szotowska I, Ledwoń A. Occurrence of bornaviruses, circoviruses and polyomaviruses in necropsy samples from parrots in Poland (2014–2024). Journal of Veterinary Research. 2026. DOI: https://doi.org/10.2478/jvetres-2026-0011